DNA photoproducts released by repair in biological fluids as biomarkers of the genotoxicity of UV radiation

Anal Bioanal Chem. 2022 Nov;414(26):7705-7720. doi: 10.1007/s00216-022-04302-1. Epub 2022 Aug 31.

Abstract

UV-induced formation of photoproducts in DNA is a major initiating event of skin cancer. Consequently, many analytical tools have been developed for their quantification in DNA. In the present work, we extended our previous liquid chromatography-mass spectrometry method to the quantification of the short DNA fragments containing photoproducts that are released from cells by the repair machinery. We designed a robust protocol including a solid-phase extraction step (SPE), an enzymatic treatment aimed at releasing individual photoproducts, and a liquid chromatography method combining on-line SPE and ultra-high-performance liquid chromatography for optimal specificity and sensitivity. We also added relevant internal standards for a better accuracy. The method was validated for linearity, repeatability, and reproducibility. The limits of detection and quantification were found to be in the fmol range. The proof of concept of the use of excreted DNA repair products as biomarkers of the genotoxicity of UV was obtained first in in vitro studies using cultured HaCat cells and ex vivo on human skin explants. Further evidence was obtained from the detection of pyrimidine dimers in the urine of human volunteers collected after recreational exposure in summer. An assay was designed to quantify the DNA photoproducts released from cells within short fragments by the DNA repair machinery. These oligonucleotides were isolated by solid-phase extraction and enzymatically hydrolyzed. The photoproducts were then quantified by on-line SPE combined with UHPLC-MS/MS with isotopic dilution.

Keywords: Biological fluids; Biomarkers; DNA damage; Solid-phase extraction; UHPLC-MS/MS.

MeSH terms

  • Biomarkers
  • Chromatography, High Pressure Liquid / methods
  • DNA / genetics
  • Humans
  • Pyrimidine Dimers* / chemistry
  • Reproducibility of Results
  • Solid Phase Extraction
  • Tandem Mass Spectrometry* / methods
  • Ultraviolet Rays / adverse effects

Substances

  • Pyrimidine Dimers
  • DNA
  • Biomarkers